This brand name is authorized in Hong Kong
The drug DAKKUKAI contains a combination of these active pharmaceutical ingredients (APIs):
1
Camphora
UNII 213N3S8275 - CAMPHOR, (-)-
|
|
2
Enoxolone
UNII P540XA09DR - ENOXOLONE
|
Enoxolone is a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin, which is a product of the plant Glycyrrhiza glabra (licorice), with potential expectorant, and gastrokinetic activities. After administration, enoxolone inhibits the metabolism of prostaglandins by both 15-hydroxyprostaglandin dehydrogenase [NAD] and prostaglandin reductase 2. |
3
Menthol
UNII BZ1R15MTK7 - LEVOMENTHOL
|
|
4
Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE
|
Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet. |
5
Tocopheryl acetate
UNII 9E8X80D2L0 - .ALPHA.-TOCOPHEROL ACETATE
|
Vitamin E is known to exert an important physiological function as an antioxidant for fats, with a sparing action on vitamin A, carotenoids and on unsaturated fatty acids. Other work has demonstrated that vitamin E is connected with the maintenance of certain factors essential for the normal metabolic cycle. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: HK | Department of Health Drug Office | Identifier(s): 66142 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.